11-95979394-A-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_032427.4(MAML2):āc.3025T>Gā(p.Phe1009Val) variant causes a missense change. The variant allele was found at a frequency of 0.000456 in 1,613,562 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Consequence
NM_032427.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAML2 | NM_032427.4 | c.3025T>G | p.Phe1009Val | missense_variant | Exon 5 of 5 | ENST00000524717.6 | NP_115803.1 | |
MAML2 | XM_011543023.4 | c.2584T>G | p.Phe862Val | missense_variant | Exon 5 of 5 | XP_011541325.1 | ||
MAML2 | XM_047427710.1 | c.2341T>G | p.Phe781Val | missense_variant | Exon 5 of 5 | XP_047283666.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000552 AC: 84AN: 152088Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000588 AC: 146AN: 248148Hom.: 0 AF XY: 0.000542 AC XY: 73AN XY: 134638
GnomAD4 exome AF: 0.000446 AC: 652AN: 1461356Hom.: 1 Cov.: 32 AF XY: 0.000498 AC XY: 362AN XY: 726918
GnomAD4 genome AF: 0.000552 AC: 84AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.000565 AC XY: 42AN XY: 74402
ClinVar
Submissions by phenotype
not provided Uncertain:1
The MAML2 p.Phe1009Val variant was not identified in the literature nor was it identified in ClinVar, Cosmic or LOVD 3.0. The variant was identified in dbSNP (ID: rs182630516) and in control databases in 184 of 279532 chromosomes at a frequency of 0.000658 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: European (Finnish) in 47 of 24982 chromosomes (freq: 0.001881), European (non-Finnish) in 131 of 127894 chromosomes (freq: 0.001024) and Other in 6 of 7112 chromosomes (freq: 0.000844), while the variant was not observed in the African, Latino, Ashkenazi Jewish, East Asian or South Asian populations. The p.Phe1009 residue is conserved across mammals and other organisms, and four out of five computational analyses (PolyPhen-2, SIFT, BLOSUM, MutationTaster) suggest that the variant may impact the protein; however, this information is not predictive enough to assume pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing at the variant location. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at